Francesca Tettamanzi

ORCID: 0000-0002-2089-6428

Also affiliated with IRCCS Humanitas Research Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “884TiP AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer”.

884TiP AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2090

N/A

0DataRank · unranked

5 citations

Yoland Antill, M.P. Barretina Ginesta, Kenichi Harano, Emma Hudson, Frederik Marmé +8 more

The secondary bile acid isoursodeoxycholate correlates with post-prandial lipemia, inflammation, and appetite and changes post-bariatric surgery

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100993

N/A

0DataRank · unranked

26 citations

Abraham S. Meijnikman, Ana Nogal, Francesco Asnicar, Ilias Attaye, Amrita Vijay +24 more